Academic Journal
Q1Journal of Allergy and Clinical Immunology
About Journal of Allergy and Clinical Immunology
Journal of Allergy and Clinical Immunology is a scholarly journal published by Elsevier Inc.. SCImago 2025 places it in Q1 with an SJR of 3.806 and an H-index of 364.
Its listed coverage is 1963-1965, 1971-2026 and its research categories include Immunology (Q1); Immunology and Allergy (Q1). The 2025 dataset reports 439 documents and 9850 citations across the latest three-year reporting window.
The Journal of Allergy and Clinical Immunology (JACI) is a highly respected, peer-reviewed medical journal that plays a crucial role in the fields of allergy, asthma, and clinical immunology. Published by the American Academy of Allergy, Asthma & Immunology (AAAAI), JACI has established itself as one of the most authoritative sources for the latest research, clinical studies, and reviews related to allergic diseases and immune system disorders.
What is JACI?
First published in 1929, JACI has a long-standing reputation for delivering cutting-edge research and clinical guidance. It is indexed in PubMed, Scopus, MEDLINE, and other major scientific databases, making it easily accessible to researchers, clinicians, and healthcare professionals worldwide.
With an impact factor consistently ranking among the top journals in allergy and immunology, JACI publishes high-quality original articles, systematic reviews, case studies, clinical trials, and position papers from leading experts in the field.
Key Areas Covered by JACI
JACI focuses on a wide range of topics within allergy and immunology, including:
-
Allergic Rhinitis and Sinusitis
-
Asthma
-
Food Allergies and Anaphylaxis
-
Atopic Dermatitis (Eczema)
-
Drug Allergies
-
Immune Deficiencies and Autoimmunity
-
Molecular and Cellular Immunology
-
Immunotherapy and Biologics
This broad scope makes JACI a valuable resource for allergists, immunologists, researchers, and even students seeking the latest evidence-based information.
Why JACI is Important for Medical Professionals
-
Evidence-Based Research: Articles in JACI are peer-reviewed and based on scientific evidence, helping clinicians make informed decisions in diagnosing and treating patients.
-
Clinical Guidelines and Reviews: The journal often publishes consensus statements and clinical practice guidelines that serve as standards in allergy and immunology.
-
Global Reach: With contributions from researchers worldwide, JACI reflects global perspectives on allergies and immune-related diseases.
Accessibility and Online Presence
JACI is available in both print and digital formats, with an official website hosted on Elsevier’s ScienceDirect platform. Many articles are open access, allowing broader dissemination of important findings.
Additionally, JACI maintains an active social media presence, sharing updates, highlights, and discussions related to new publications, making it easier for professionals to stay updated.
Related Publications
JACI is closely associated with its companion journal, JACI: In Practice, which focuses more on real-world clinical applications and case-based learning, while JACI itself emphasizes foundational and translational research.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The Journal of Allergy and Clinical Immunology (JACI) stands as one of the most respected peer-reviewed medical journals dedicated to the fields of allergy, asthma, and immunology. Published by the American Academy of Allergy, Asthma & Immunology (AAAAI), this high-impact journal serves as a primary source for clinicians, researchers, and healthcare professionals seeking the latest scientific advancements and clinical practices related to allergic and immunologic diseases.
Comprehensive Coverage of Allergy and Immunology
The scope of the Journal of Allergy and Clinical Immunology is broad, encompassing all aspects of allergic and immunologic disorders. This includes, but is not limited to:
-
Allergic Rhinitis and Asthma
JACI regularly publishes cutting-edge research on the pathogenesis, diagnosis, and management of respiratory allergic conditions. These include asthma, seasonal allergies, and sinusitis, providing valuable insights into prevention and treatment. -
Food Allergies and Drug Hypersensitivity
The journal features original studies and reviews on adverse immune reactions to food and medications, helping clinicians stay informed about risk factors, diagnostic tests, and emerging therapies. -
Immunodeficiency and Autoimmune Diseases
JACI explores both primary and secondary immunodeficiencies, offering essential data on immune system dysfunctions and the latest advancements in diagnostic technologies and therapies. -
Skin Disorders
Topics such as atopic dermatitis, urticaria, and contact dermatitis are frequently covered, helping dermatologists and immunologists better understand the immune-related mechanisms of skin diseases. -
Mechanisms of Disease
A significant portion of the journal is devoted to basic immunological research, which explains the cellular and molecular mechanisms involved in allergic and immune responses.
Types of Articles Published
To support its broad scope, JACI publishes a variety of content types:
-
Original research articles
-
Clinical reviews
-
Case studies
-
Guidelines and consensus statements
-
Editorials and opinion pieces
-
Letters to the editor
Each article undergoes a rigorous peer-review process to ensure high scientific and ethical standards.
Global Impact and Readership
The Journal of Allergy and Clinical Immunology is internationally recognized, with a wide readership among researchers, clinicians, and medical educators. Its high impact factor and wide citation rate make it a valuable resource in both academic and clinical settings. By fostering collaboration and knowledge sharing, JACI contributes to improved patient outcomes worldwide.
Commitment to Advancing Science
JACI is committed to promoting the latest innovations in allergy and clinical immunology. The journal supports translational research that bridges laboratory findings with real-world patient care. It also encourages global submissions, ensuring a diverse representation of perspectives and findings.
Recent Research Articles
Latest publications matched automatically by ISSN.
Predicting asthma prevalence across US communities by integrating social vulnerability and environmental risk with machine learning
Thinh H. Nguyen, Saleh Alsulami, Teresia T. Pham, Diane Story et al.
2026-09 · DOI: 10.1016/j.jaci.2026.04.015Associations of rurality, child opportunity, and distance with use of pediatric asthma specialists
James Bohnhoff, Anya Cutler, Elizabeth A. Jacobs, Wanda Phipatanakul et al.
2026-09 · DOI: 10.1016/j.jaci.2026.04.020News beyond our pages
2026-09 · DOI: 10.1016/j.jaci.2026.07.005The IL-9R/Arg1 pathway promotes polyamine metabolism in human airway macrophages
Wenwu Zhang, In Su Cheon, Abigail Pajulas, Anthony L. Sinn et al.
2026-09 · DOI: 10.1016/j.jaci.2026.08.016HLA-B alleles confer susceptibility to sulfasalazine-induced severe cutaneous adverse reactions
Chuang-Wei Wang, Wei-Ti Chen, Chun-Bing Chen, Chia-Yu Chu et al.
2026-09 · DOI: 10.1016/j.jaci.2026.04.017Editorial Board
2026-09 · DOI: 10.1016/s0091-6749(26)00535-xNovel olfactory cleft computed tomography staging system reveals a trizone anatomic model and biphasic progression in central compartment atopic disease
Xingchen Pan, Yankun Li, Xincen Jiang, Benjamin S. Bleier et al.
2026-09 · DOI: 10.1016/j.jaci.2026.04.014Brief Overview of This Month's JACI
2026-09 · DOI: 10.1016/s0091-6749(26)00533-6Post–genome-wide association study variant-to-function challenges in asthma research
Xiaoyuan Zhong, Isabella M. Salamone, Marcelo A. Nóbrega, Xin He et al.
2026-09 · DOI: 10.1016/j.jaci.2026.06.017Coordinated changes in oral propionate, oral microbiota, and peripheral blood inflammatory processes during peanut oral immunotherapy
Lingdi Zhang, Yoojin Chun, Samantha Valeiron, Galina Grishina et al.
2026-09 · DOI: 10.1016/j.jaci.2026.08.015Characterization of missense variants in the signal peptide of C1 esterase inhibitor
Zhen Ren, John Bao, Shuangxiao Zhao, H. James Wedner et al.
2026-09 · DOI: 10.1016/j.jaci.2026.04.024Dupilumab efficacy and safety in patients with allergic bronchopulmonary aspergillosis
Arnaud Bourdin, Jonathan Corren, Anand Shah, Caroline G. Baxter et al.
2026-09 · DOI: 10.1016/j.jaci.2026.08.021Tamoxifen-driven neutrophil reprogramming protects from pulmonary Granulibacter bethesdensis infection in chronic granulomatous disease
Atul Sharma, Rakhee Rathnam Kalari Kandy, Rahul S. Jasrotia, Arun Chauhan et al.
2026-09 · DOI: 10.1016/j.jaci.2026.05.026Lessons learned from clinical trials of thymic stromal lymphopoietin (TSLP) inhibition
Jonathan Corren, Larry Borish, Christopher Brightling, Joseph K. Han et al.
2026-09 · DOI: 10.1016/j.jaci.2026.08.022Table of Contents
2026-09 · DOI: 10.1016/s0091-6749(26)00534-8Upper airway microbiome interacts with GSDMB and ORMDL3 asthma risk SNPs to influence early-life wheeze risk
Holly M. Steininger, Kathryn E. McCauley, Gabe E. Braga, Andréanne Morin et al.
2026-09 · DOI: 10.1016/j.jaci.2026.05.021Information for Readers
2026-09 · DOI: 10.1016/s0091-6749(26)00537-3Corrigendum
2026-09 · DOI: 10.1016/j.jaci.2026.06.014Early intervention with secukinumab prevents epigenetic scar development in new-onset psoriasis: STEPIn mechanistic substudy results
Johann E. Gudjonsson, Katharina Bier, Swann Gaulis, Lam C. Tsoi et al.
2026-09 · DOI: 10.1016/j.jaci.2026.04.028Long-acting IL-7 restores T-cell reconstitution in a humanized mouse model of lymphopenia
Ainhoa Pérez-Díez, Xiangdong Liu, Ashlynn Bennett, Marliece Barrios et al.
2026-09 · DOI: 10.1016/j.jaci.2026.04.027Reviews
Community Reviews
Version History
April 21, 2025 at 6:28 am
April 21, 2025